Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertensionAcquisition reinforces Essential ...
October 30, 2006 (Salt Lake City) — The prostaglandin iloprost, delivered via inhalation (Ventavis), appears to be safe and well tolerated in children with pulmonary arterial hypertension (PAH), but ...
Actelion Pharmaceuticals has launched an increased strength formulation of Ventavis (iloprost inhalation solution), an inhaled prostacyclin analogue, for the treatment of pulmonary arterial ...
Iloprost is a medication used to treat disorders like pulmonary arterial hypertension, scleroderma, Raynaud syndrome, and other disorders that cause blood vessel constriction and poor blood flow in ...
CoTherix Inc. submitted a new drug application requesting approval of Ventavis as a therapy for patients with pulmonary arterial hypertension. Ventavis, an inhaled formulation of iloprost, a ...
Acquisition reinforces Essential Pharma’s mission to serve the needs of rare disease populations and enhances reputation as a trusted partner for continued access to niche medicines Egham, UK – 17 ...
Egham, UK - 17 February 2026 - Essential Pharma ("Essential” or "the Company”), a global specialty pharmaceutical company, today announces the acquisition of Ventavis® (iloprost trometamol) from Bayer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results